Astera Labs (NASDAQ:ALAB) Price Target Cut to $400.00 by Analysts at Royal Bank Of Canada

Astera Labs (NASDAQ:ALAB) had its price objective trimmed by Royal Bank Of Canada from $500.00 to $400.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

A number of other equities research analysts also recently commented on ALAB. Needham & Company LLC lowered their price objective on Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 target price for the company in a research note on Wednesday. Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Roth Capital reiterated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Morgan Stanley raised their price target on Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Twelve analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $318.00.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $223.27 on Wednesday. The firm has a market cap of $38.73 billion, a P/E ratio of 88.95 and a beta of 3.85. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The firm’s 50 day moving average price is $304.94 and its 200 day moving average price is $255.78.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The company had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. During the same period in the previous year, the firm posted $0.49 EPS. Astera Labs’s revenue was up 153.6% on a year-over-year basis. As a group, equities analysts predict that Astera Labs will post 2.71 EPS for the current year.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock valued at $123,408,470 in the last ninety days. 10.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Astera Labs in the 2nd quarter worth about $6,609,581,000. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the 2nd quarter worth about $1,061,791,000. Atreides Management LP grew its holdings in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi grew its holdings in shares of Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock worth $206,139,000 after purchasing an additional 823,477 shares during the period. Finally, Deutsche Bank AG acquired a new stake in Astera Labs during the 2nd quarter worth approximately $325,602,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
• Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
• Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.